Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Empower: tDCS for Major Depressive Disorder at Home

NCT: NCT05202119 · COMPLETED

NCT IDNCT05202119
StatusCOMPLETED
Start Date2022-05-12
Completion2023-08-31

Brief Summary

A two-center trial to investigate whether or not active stimulation with the Flow FL-100 tDCS device is superior to sham stimulation for the treatment of major depressive disorder when used at home. Participants perform up to 36 tDCS sessions by themselves without supervision during a blinded 10-week phase, and then 30 more sessions during an unblinded open-label phase.

Frequently Asked Questions

What is Empower: tDCS for Major Depressive Disorder at Home?

Empower: tDCS for Major Depressive Disorder at Home is a clinical trial registered under NCT05202119. Current status: COMPLETED.

What is the status of NCT05202119?

The current status of NCT05202119 (Empower: tDCS for Major Depressive Disorder at Home) is: COMPLETED.

When did Empower: tDCS for Major Depressive Disorder at Home start?

Empower: tDCS for Major Depressive Disorder at Home started on 2022-05-12.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.